Chronic Lung Diseases
6
0
1
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 6 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (6)
An Observational Study Into Antimicrobial Resistance in Patients With a Chronic Lung Disease
Clinical Information System Impact on Hospitalized Patients With Chronic Disease
Clinical Utility of LIBS Multi-Element Imaging and the IFF Algorithm in Chronic Lung Diseases
Chronic Lung Disease and COVID-19: Understanding Severity, Recovery and Rehabilitation Needs
Enhanced External Counterpulsation for Patients With Ventilation Disorders
Written Disclosure Therapy for Anxiety and Stress in Patients With Chronic Lung Disease